We are not aware of any published report of upregulation of IL-6 by B(a)P although previously B(a)P has been shown to increase the production of pro-inflammation IL-8 via NFκB activation in lung cancer A549 cell line (Pei et al. 2002). This evidence concerns the gene NFKB1 and lung carcinoma.